Advanced search
Publication Cover
Scandinavian Journal of Urology Volume 52, 2018 - Issue 2
Journal homepage
1,624
Views
11
CrossRef citations to date
0
Altmetric
Article

Nationwide population-based study on the use of novel antiandrogens in men with prostate cancer in Sweden

Ingela Franck LissbrantDepartment of Oncology, Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-8612-9814View further author information
ORCID Icon,
Eugenio VentimigliaDivision of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; ;Department of Surgical Sciences, Uppsala University, Uppsala, Sweden; View further author information
,
David RobinsonDepartment of Urology, Ryhov County Hospital, Jönköping, Sweden; View further author information
,
Magnus TörnblomDepartment of Surgery, Visby County Hospital, Visby, Sweden; View further author information
,
Marie Hjälm-ErikssonDepartment of Surgery, Capio St. Görans Hospital, Stockholm, Sweden; ;Department of Oncology–Pathology, Karolinska Institutet, Stockholm, Sweden; View further author information
,
Mats LambeRegional Cancer Centre, Uppsala University Hospital, Uppsala, SwedenView further author information
,
Yasin FolkvaljonDepartment of Surgical Sciences, Uppsala University, Uppsala, Sweden; ORCID Iconhttp://orcid.org/0000-0003-1735-721XView further author information
ORCID Icon &
Pär StattinDepartment of Surgical Sciences, Uppsala University, Uppsala, Sweden; View further author information
 show all
Pages 143-150 | Received 06 Jul 2017, Accepted 05 Jan 2018, Published online: 01 Feb 2018

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Hari T. Vigneswaran, Anna Warnqvist, Therese M. L. Andersson, Amy Leval, Martin Eklund, Tobias Nordström, Sandra Eloranta, Frida Schain, Lindsay Dearden, Johan Liwing, Maneesha Mehra, Sandhya Nair, Andreas Pettersson, Olof Akre & Markus Aly. (2021) Real world treatment utilization patterns in patients with castration-resistant prostate cancer. Scandinavian Journal of Urology 55:4, pages 299-306.
Read now
Johanna Svensson, Ingela Franck Lissbrant, Oskar Gauffin, Marie Hjälm-Eriksson, Suzanne Kilany, Karin Fagerlund & Pär Stattin. (2021) Time spent in hormone-sensitive and castration-resistant disease states in men with advanced prostate cancer, and its health economic impact: registry-based study in Sweden. Scandinavian Journal of Urology 55:1, pages 1-8.
Read now
Mohammed Alghazali, Annica Löfgren, Leif Jørgensen, Maja Svensson, Karin Fagerlund & Anders Bjartell. (2019) A registry-based study evaluating overall survival and treatment duration in Swedish patients with metastatic castration-resistant prostate cancer treated with enzalutamide. Scandinavian Journal of Urology 53:5, pages 312-318.
Read now

Articles from other publishers (8)

Rolf Gedeborg, Fredrik Sandin, Camilla Thellenberg-Karlsson, Johan Styrke, Ingela Franck Lissbrant, Hans Garmo & Pär Stattin. (2023) Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden. Scandinavian Journal of Urology 58.
Crossref
Pär Stattin, Marcus Westerberg, Ingela Franck Lissbrant, Marie Hjälm Eriksson, Anders Kjellman, Anders Ullén, Zdravko Vassilev, Per Sandstrom, Rachel Weinrib, David Martinez & Xabier Garcia-Albeniz. (2023) Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden. Clinical Genitourinary Cancer 21:1, pages 107.e1-107.e9.
Crossref
Jason Hu, Armen G. Aprikian, Ramy R. Saleh & Alice Dragomir. (2022) Utilization Trends of Novel Hormonal Agents in Metastatic Castration-Resistant Prostate Cancer in Quebec. Current Oncology 29:11, pages 8626-8637.
Crossref
Eugenio Ventimiglia, Anna Bill-Axelson, Jan Adolfsson, Markus Aly, Martin Eklund, Marcus Westerberg, Pär Stattin & Hans Garmo. (2022) Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data. European Urology Open Science 44, pages 46-51.
Crossref
Maximilian Marhold, Gero Kramer, Michael Krainer & Clémentine Le Magnen. (2022) The prostate cancer landscape in Europe: Current challenges, future opportunities. Cancer Letters 526, pages 304-310.
Crossref
Kerri Beckmann, Hans Garmo, Ingela Franck Lissbrant & Pär Stattin. (2021) The Value of Real-World Data in Understanding Prostate Cancer Risk and Improving Clinical Care: Examples from Swedish Registries. Cancers 13:4, pages 875.
Crossref
Giuseppe Fallara, Ingela Franck Lissbrant, Johan Styrke, Francesco Montorsi, Hans Garmo & Pär Stattin. (2020) Observational study on time on treatment with abiraterone and enzalutamide. PLOS ONE 15:12, pages e0244462.
Crossref
Andri Wilberg Orrason, Marcus Westerberg, Hans Garmo, Ingela Franck Lissbrant, David Robinson & Pär Stattin. (2020) Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016: a nationwide, population‐based study in Sweden. BJU International 126:1, pages 142-151.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.